SCHEMBL9954231

SCHEMBL9954231

CCC(=O)Nc1cnc[nH]1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH2 P25021 1/20 0.43
HRH1 P35367 1/20 0.43
HRH4 Q9H3N8 1/20 0.43
HRH3 Q9Y5N1 1/20 0.43
QPCT Q16769 1/20 0.40
QPCTL Q9NXS2 1/20 0.40
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 3/20 0.39
MAPT P10636 3/20 0.39
LMNA P02545 2/20 0.39
CYP3A4 P08684 2/20 0.39
MAPK1 P28482 2/20 0.39
PKM P14618 1/20 0.39
CCR6 P51684 1/20 0.39
MCL1 Q07820 1/20 0.39
ATM Q13315 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
APOBEC3G Q9HC16 1/20 0.39
GABRA1 P14867 1/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8425012 0.86 HRH2 (0.45) HRH2HRH1HRH4HRH3ALDH1A1
SCHEMBL8818411 0.78 NPC1 (0.42) QPCTQPCTLALDH1A1KDM4EMAPT
SCHEMBL18372644 0.77 HRH2 (0.41) HRH2HRH4HRH3CYP3A4MAPK1
SCHEMBL5518230 0.75
SCHEMBL14253913 0.74 HRH2 (0.42) HRH2HRH1HRH4HRH3QPCT
SCHEMBL4412289 0.74 CYP3A4 (0.48) ALDH1A1KDM4EMAPTLMNACYP3A4
SCHEMBL13134161 0.73 JAK3 (0.42) QPCTQPCTLALDH1A1KDM4EMAPT
SCHEMBL5217908 0.71
SCHEMBL17493877 0.71 CA1 (0.49) HRH4HRH3NPC1RAB9A
SCHEMBL13134163 0.70 TGM2 (0.40) ALDH1A1KDM4ELMNACYP3A4NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2655330-A1 SUBSTITUTED PYRIDINES AS SODIUM CHANNEL BLOCKERS Purdue Pharma LP (US) 2013-10-30 EP disclosed
WO-2012085650-A1 SUBSTITUTED PYRIDINES AS SODIUM CHANNEL BLOCKERS PURDUE PHARMA L.P. (US) 2012-06-28 WO disclosed